Jiawei Shang

955 total citations · 1 hit paper
24 papers, 684 citations indexed

About

Jiawei Shang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Jiawei Shang has authored 24 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Jiawei Shang's work include Metabolomics and Mass Spectrometry Studies (5 papers), Cancer-related molecular mechanisms research (4 papers) and Ginseng Biological Effects and Applications (3 papers). Jiawei Shang is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (5 papers), Cancer-related molecular mechanisms research (4 papers) and Ginseng Biological Effects and Applications (3 papers). Jiawei Shang collaborates with scholars based in China, United Kingdom and United States. Jiawei Shang's co-authors include Yingchuan Li, Yongmei Cao, Ping Feng, Wei-Feng Huang, Fang Wu, Qin Tan, Haijun Zhang, Jian Xiao, Xiaoping Zhang and Yong Guo and has published in prestigious journals such as Food Chemistry, International Journal of Molecular Sciences and Cell Death and Differentiation.

In The Last Decade

Jiawei Shang

21 papers receiving 679 citations

Hit Papers

Inhibitor of apoptosis-st... 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury
    2020 400 citations Yingchuan Li, Yongmei Cao et al. Cell Death and Differentiation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiawei Shang China 12 379 275 262 92 81 24 684
Yuebo Huang China 12 315 0.8× 154 0.6× 151 0.6× 87 0.9× 60 0.7× 14 587
Jingwen Xia China 15 310 0.8× 147 0.5× 199 0.8× 95 1.0× 64 0.8× 36 622
Wenjing Song China 14 408 1.1× 118 0.4× 201 0.8× 49 0.5× 63 0.8× 42 699
Jiantong Hou China 12 410 1.1× 178 0.6× 257 1.0× 45 0.5× 83 1.0× 30 837
Jian‐Bing Xiong China 13 406 1.1× 220 0.8× 102 0.4× 283 3.1× 94 1.2× 20 779
Xuemei Lian China 14 309 0.8× 124 0.5× 154 0.6× 137 1.5× 87 1.1× 23 642
Chongxiu Yue China 6 553 1.5× 662 2.4× 485 1.9× 101 1.1× 51 0.6× 7 1.0k
Zixiong Zhou China 13 211 0.6× 174 0.6× 162 0.6× 92 1.0× 200 2.5× 31 598
Shuying Miao China 12 222 0.6× 134 0.5× 99 0.4× 51 0.6× 68 0.8× 22 526

Countries citing papers authored by Jiawei Shang

Since Specialization
Citations

This map shows the geographic impact of Jiawei Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiawei Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiawei Shang more than expected).

Fields of papers citing papers by Jiawei Shang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiawei Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiawei Shang. The network helps show where Jiawei Shang may publish in the future.

Co-authorship network of co-authors of Jiawei Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiawei Shang. A scholar is included among the top collaborators of Jiawei Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiawei Shang. Jiawei Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Yongmei, Yong Zhong, Jiawei Shang, et al.. (2025). FLRT3 Overexpression Attenuates Ischemia–Reperfusion Induced Vascular Hyperpermeability and Lung Injury Through RND3. Lung. 203(1). 39–39.
2.
Shang, Jiawei, et al.. (2023). Computational method for rapid screening of the metabolites of Pulsatilla chinensis in rats using UHPLC-Q-TOF/MS combined with mass spectrum-based orthogonal projection. Journal of Pharmaceutical and Biomedical Analysis. 229. 115345–115345. 2 indexed citations
3.
Chen, Yuzhou, et al.. (2023). Trigonometric phase net: a robust method for extracting wrapped phase from fringe patterns under non-ideal conditions. Optical Engineering. 62(7). 1 indexed citations
4.
Shang, Jiawei, et al.. (2023). HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis. BMC Molecular and Cell Biology. 24(1). 2–2. 18 indexed citations
5.
Shang, Jiawei, Jianxin Wang, Jiaxi Li, et al.. (2023). Integrative strategy for quality control of Radix Bupleuri based on non-targeted metabolomic profiling and molecular networking. Analytical and Bioanalytical Chemistry. 415(5). 961–974. 3 indexed citations
6.
Wang, Jianxin, et al.. (2023). Experimental validation for mechanisms of Qizhiweitong particles against Chronic Non-atrophic gastritis based on metabolomics and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis. 234. 115549–115549. 1 indexed citations
7.
8.
Shang, Jiawei, Jianxin Wang, Jiaxi Li, et al.. (2022). Quality control of Zingiberis Rhizoma and its processed products by UHPLC-Q-TOF/MS-based non-targeted metabonomics combining with SIBDV method. Food Research International. 154. 111021–111021. 19 indexed citations
9.
10.
11.
Wu, Fang, Wei-Feng Huang, Qin Tan, et al.. (2021). ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1. Cell Death and Disease. 12(6). 614–614. 35 indexed citations
12.
Cao, Yongmei, Wei-Feng Huang, Fang Wu, et al.. (2021). ZFP36 protects lungs from intestinal I/R-induced injury and fibrosis through the CREBBP/p53/p21/Bax pathway. Cell Death and Disease. 12(7). 685–685. 26 indexed citations
13.
Feng, Ping, Yingchuan Li, Yongmei Cao, et al.. (2021). Metabolomics Analysis of the Development of Sepsis and Potential Biomarkers of Sepsis‐Induced Acute Kidney Injury. Oxidative Medicine and Cellular Longevity. 2021(1). 6628847–6628847. 21 indexed citations
14.
15.
Li, Yingchuan, Yongmei Cao, Jian Xiao, et al.. (2020). Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death and Differentiation. 27(9). 2635–2650. 400 indexed citations breakdown →
16.
Guo, Xinxin, et al.. (2020). Glycyrrhetinic Acid‐Induced MiR‐663a Alleviates Hepatic Stellate Cell Activation by Attenuating the TGF‐β/Smad Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2020(1). 3156267–3156267. 15 indexed citations
17.
Feng, Ping, Yong Guo, Yongmei Cao, et al.. (2019). Metabolomics Analysis of the Renal Cortex in Rats With Acute Kidney Injury Induced by Sepsis. Frontiers in Molecular Biosciences. 6. 152–152. 32 indexed citations
18.
Shang, Jiawei, et al.. (2019). Expression and significance of urinary microRNA in patients with chronic hepatitis B. Medicine. 98(37). e17143–e17143. 8 indexed citations
19.
Cao, Yongmei, Yujing Liu, Jiawei Shang, et al.. (2019). Ang-(1-7) treatment attenuates lipopolysaccharide-induced early pulmonary fibrosis. Laboratory Investigation. 99(12). 1770–1783. 30 indexed citations
20.
Zhang, Yiwei, Kun Tian, Yan Wang, et al.. (2016). The Effects of Aquaporin-1 in Pulmonary Edema Induced by Fat Embolism Syndrome. International Journal of Molecular Sciences. 17(7). 1183–1183. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuebo Huang Breakdown of academic impact, for papers by Jingwen Xia Breakdown of academic impact, for papers by Wenjing Song Breakdown of academic impact, for papers by Jiantong Hou Breakdown of academic impact, for papers by Jian‐Bing Xiong Breakdown of academic impact, for papers by Xuemei Lian Breakdown of academic impact, for papers by Chongxiu Yue Breakdown of academic impact, for papers by Zixiong Zhou Breakdown of academic impact, for papers by Shuying Miao
Rankless by CCL
2026